NCT04983654 Functional and Mechanistic Characterization of Limb Ulcers in Patients With Sickle Cell Disease Status COMPLETED Phase NA
NCT04983264 A Study to Evaluate GBT021601-012 Single Dose and Multiple Dose in Participants With Sickle Cell Disease (SCD) Status COMPLETED Phase PHASE1
NCT04935879 A Study to Assess the Safety and Efficacy of Inclacumab in Participants With Sickle Cell Disease Experiencing Vaso-occlusive Crises Status COMPLETED Phase PHASE3
NCT04930445 Oxbryta® Product Registry An Observational Study Designed to Evaluate the Effect of Oxbryta in Individuals With SCD Status TERMINATED Phase N/A
NCT04930328 Retrospective Real World Oxbryta® Data Collection and Analysis Study Status COMPLETED Phase N/A
NCT04927247 A Study of a Single Dose of Inclacumab to Reduce Re-admission in Participants With Sickle Cell Disease and Recurrent Vaso-occlusive Crises Status TERMINATED Phase PHASE3
NCT04917120 Observational Prospective Study Measuring the Impact of the Use of a Hypnotic Script Associated With Virtual Reality on the Pain of the Child's Sickle Cell During a Vaso-occlusive Crisis Status COMPLETED Phase NA
NCT04912869 A Study Evaluating the Safety, Pharmacokinetics, Pharmacodynamics and Efficacy of Crovalimab for the Management of Acute Uncomplicated Vaso-Occlusive Episodes (VOE) in Participants With Sickle Cell Disease (SCD). Status COMPLETED Phase PHASE1
NCT04911049 Prevalence and Pathophysiology of Systemic Arterial Pressure Abnormalities in Childhood Sickle Cell Disease Status UNKNOWN Phase N/A
NCT04906707 Home-Based Intervention for Chronic Pain in Adults With Sickle Cell Disease Status COMPLETED Phase NA
NCT04906447 Hybrid Effectiveness-Implementation Trial of Guided Relaxation and Acupuncture for Chronic Sickle Cell Disease Pain Status COMPLETED Phase PHASE2
NCT04877054 Pilot Evaluation of a Motivational Interviewing Intervention Targeting Adherence Behaviors in Youth With Sickle Cell Disease Status COMPLETED Phase NA
NCT04864041 Evaluation of Left Ventricular Function by Speckle Tracking Echocardiography in Patient Hospitalised in Intensive Care Unit for Vaso-occlusive Crisis Status UNKNOWN Phase N/A
NCT04853576 A Study Evaluating the Safety and Efficacy of EDIT-301 in Participants With Severe Sickle Cell Disease (RUBY) Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT04839354 Sickle Cell Disease Treatment With Arginine Therapy (STArT) Trial Status COMPLETED Phase PHASE3
NCT04819841 Gene Correction in Autologous CD34+ Hematopoietic Stem Cells (HbS to HbA) to Treat Severe Sickle Cell Disease Status RECRUITING Phase PHASE1/PHASE2